Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Suffering from missteps, drugmaker Teva struggles to heal own ills - The Times of Israel
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva and Allergan to Pay $120 Million in Third Kentucky Settlement - news .law
Sanofi continues expansion spree by licencing Teva's IBD drug for $1.5bn - Pharmaceutical Technology
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva reaches $4.25 billion settlement over alleged role in opioid crisis - CBS News
Teva quits brand lobby PhRMA, in line to lead generic lobby AAM - STAT
Teva Pharmaceutical: Slow Road To A Higher Share Price (NYSE:TEVA) | Seeking Alpha
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate' | Markets Insider
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
Teva CEO Richard Francis, after 120 days at the helm, preps grand strategic reveal
Teva Pharmaceuticals, Alvotech Expand Strategic Biosimilars Pact | Contract Pharma
Teva Concludes Nationwide Opioids Settlement Agreement
Teva Rockets After Hiring Former Novo Nordisk Exec As CEO | Investor's Business Daily
Here's Why Teva Pharma Stock Is Soaring Today
Teva Restructuring Coming Together, Rebuilding Confidence in the Company | BioSpace
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Teva CEO stands down during troubled times - MedCity News
Teva profit plummets, stock slides | Ctech
